PHARMADVANCE
ActiveSummary
PHARMADVANCE has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,136 and a net result of €43,820. Equity is growing by ~50% per year across the filed fiscal years. Its solvency ranks better than 19% of 10552 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability43▲+7
Solvency34▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
1.1%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,000 at 30 days acceptable
Liquidity tight (current ratio 1.03 against 1.04 in 2024; short-term debt: 68.1% and cash: 4.6% of total assets), and 91.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
8.5%
Return on assets
4.1%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 10552 sector peers (2025).
NBB · sector comparisonPosition among 10552 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
23 d early
2024
21 d late
2023
84 d late
2022
90 d late
2021
33 d late
2020
61 d late
2019
17 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 40 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 September (4 of the last 5 filed years within 56 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€43,820▲ 280%
2024 · €11,539
Working capital
€19,654▼ 19.6%
2024 · €24,453
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€71,457▲ 39.8%€24,100▼ 66.3%€10,709▼ 55.6%€52,695▲ 392%€65,716▲ 24.7%
Net result€70,183within the sector's middle half▲ 44.0%€36,257within the sector's middle half▼ 48.3%€9,431within the sector's middle half▼ 74.0%€11,539within the sector's middle half▲ 22.4%€43,820within the sector's middle half▲ 280%
Equity€2,088below the sector's middle half€38,345below the sector's middle half▲ 1,736%€47,776below the sector's middle half▲ 24.6%€59,315below the sector's middle half▲ 24.2%€91,136within the sector's middle half▲ 53.6%
Total assets€1.3mwithin the sector's middle half▲ 1.7%€1.2mwithin the sector's middle half▼ 4.0%€1.2mwithin the sector's middle half▼ 5.3%€1.1mwithin the sector's middle half▼ 6.5%€1.1mwithin the sector's middle half▼ 2.5%
Debt€1.3m▼ 3.7%€1.2m▼ 6.8%€1.1m▼ 6.2%€1.0m▼ 7.8%€975,360▼ 5.7%
Working capital€93,888within the sector's middle half▲ 953%€79,119within the sector's middle half▼ 15.7%€50,794within the sector's middle half▼ 35.8%€24,453within the sector's middle half▼ 51.9%€19,654within the sector's middle half▼ 19.6%
Solvency0.2%below the sector's middle half▲ 5.5pp3.1%below the sector's middle half▲ 2.9pp4.1%below the sector's middle half▲ 1.0pp5.4%below the sector's middle half▲ 1.3pp8.5%below the sector's middle half▲ 3.1pp
Current ratio1.14within the sector's middle half▲ 0.121.12within the sector's middle half▼ 0.021.07within the sector's middle half▼ 0.041.04within the sector's middle half▼ 0.041.03within the sector's middle half▼ 0.01
Return on assets (ROA)5.5%within the sector's middle half▲ 1.6pp2.9%within the sector's middle half▼ 2.5pp0.8%within the sector's middle half▼ 2.1pp1.1%within the sector's middle half▲ 0.2pp4.1%within the sector's middle half▲ 3.1pp
Staff (FTE)3.3within the sector's middle half▲ 13.8%4.1within the sector's middle half▲ 24.2%3.7within the sector's middle half▼ 9.8%3.8within the sector's middle half▲ 2.7%4within the sector's middle half▲ 5.3%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 25% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets
€320,481 ▼ 14.0%
Current assets
€746,015 ▲ 3.4%
Equity and liabilities €1.1m
Equity
€91,136 ▲ 53.6%
Debt
€975,360 ▼ 5.7%
Debt's share of the balance-sheet total falls from 94.6% to 91.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€118,549▲
2024 · €106,542
Cash flow
€96,653▲
2024 · €65,386
Quick ratio
0.89▲
2024 · 0.87
Debt to equity
10.70▼
2024 · 17.45
ROE
48.1%▲
2024 · 19.5%
Interest coverage
2.30▲
2024 · 1.95
Debt ≤ 1 year
€726,360▲
2024 · €696,755
Debt > 1 year
€249,000▼
2024 · €338,000
Income taxes
€27,730▲
2024 · €22,684
Staff costs
€179,404▼
2024 · €212,954
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,251 companies that looked in July 2024 the way this one looks now, 2.6% went bankrupt within 24 months and 94% are still going.
- Micro
- 5 to 10 years old
- solvency under 10%
- a profit under 5% of the balance sheet
2.6%
went bankrupt
2.7%
stopped otherwise
94%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,251 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €1,500 | €4,021 | €0 | - | - | - |
| Remuneration, social security and pensions62 | €159,836 | €179,209 | €185,796 | €212,954 | €179,404 | ▼ 15.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €112,067 | €53,968 | €54,834 | €53,847 | €52,833 | ▼ 1.9% |
| Other operating charges640/8 | €1,118 | €1,246 | €1,052 | €9,220 | €1,343 | ▼ 85.4% |
| Gross operating margin9900 | €344,477 | €258,523 | €252,392 | €328,716 | €299,297 | ▼ 8.9% |
| Operating profit (loss)9901 | €71,457 | €24,100 | €10,709 | €52,695 | €65,716 | ▲ 24.7% |
| Financial income75/76B | €17,328 | €38,691 | €18,853 | €36,118 | €57,374 | ▲ 58.9% |
| Recurring financial income75 | €17,328 | €38,691 | €18,853 | €36,118 | €57,374 | ▲ 58.9% |
| Financial charges65/66B | €12,782 | €11,794 | €12,757 | €54,590 | €51,539 | ▼ 5.6% |
| Recurring financial charges65 | €12,782 | €11,794 | €12,757 | €54,590 | €51,539 | ▼ 5.6% |
| Profit (loss) for the period before taxes9903 | €76,003 | €50,998 | €16,805 | €34,224 | €71,550 | ▲ 109% |
| Income taxes67/77 | €5,820 | €14,741 | €7,374 | €22,684 | €27,730 | ▲ 22.2% |
| Profit (loss) for the period9904 | €70,183 | €36,257 | €9,431 | €11,539 | €43,820 | ▲ 280% |
| Profit (loss) for the period to be appropriated9905 | €70,183 | €36,257 | €9,431 | €11,539 | €43,820 | ▲ 280% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.3m | €1.2m | €1.2m | €1.1m | €1.1m | ▼ 2.5% |
| Fixed assets21/28 | €513,200 | €475,226 | €423,982 | €372,863 | €320,481 | ▼ 14.0% |
| Intangible fixed assets21 | €140,000 | €112,000 | €84,000 | €56,000 | €28,000 | ▼ 50.0% |
| Tangible fixed assets22/27 | €373,200 | €363,226 | €339,982 | €316,863 | €292,481 | ▼ 7.7% |
| Land and buildings22 | €360,357 | €336,888 | €314,833 | €294,099 | €274,596 | ▼ 6.6% |
| Plant, machinery and equipment23 | €1,658 | €14,511 | €16,490 | €15,336 | €13,608 | ▼ 11.3% |
| Furniture and vehicles24 | €6,303 | €11,826 | €8,658 | €7,428 | €4,277 | ▼ 42.4% |
| Assets under construction and advance payments27 | €4,882 | - | - | - | - | - |
| Current assets29/58 | €772,649 | €759,463 | €745,530 | €721,207 | €746,015 | ▲ 3.4% |
| Stocks and contracts in progress3 | €113,808 | €124,249 | €126,606 | €113,862 | €99,915 | ▼ 12.2% |
| Stocks30/36 | €113,808 | €124,249 | €126,606 | €113,862 | €99,915 | ▼ 12.2% |
| Amounts receivable within one year40/41 | €133,950 | €102,290 | €132,841 | €163,902 | €218,257 | ▲ 33.2% |
| Trade receivables40 | €130,662 | €93,638 | €107,107 | €135,010 | €160,599 | ▲ 19.0% |
| Other amounts receivable41 | €3,288 | €8,653 | €25,734 | €28,892 | €57,658 | ▲ 99.6% |
| Current investments50/53 | €377,382 | €448,854 | €484,208 | €431,255 | €376,682 | ▼ 12.7% |
| Cash at bank and in hand54/58 | €145,153 | €83,160 | €1 | €10,185 | €49,161 | ▲ 383% |
| Deferred charges and accrued income490/1 | €2,357 | €910 | €1,874 | €2,004 | €1,999 | ▼ 0.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.3m | €1.2m | €1.2m | €1.1m | €1.1m | ▼ 2.5% |
| Equity10/15 | €2,088 | €38,345 | €47,776 | €59,315 | €91,136 | ▲ 53.6% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Profit (loss) carried forward14 | -€16,512 | €19,745 | €29,176 | €40,715 | €72,536 | ▲ 78.2% |
| Amounts payable17/49 | €1.3m | €1.2m | €1.1m | €1.0m | €975,360 | ▼ 5.7% |
| Amounts payable after more than one year17 | €605,000 | €516,000 | €427,000 | €338,000 | €249,000 | ▼ 26.3% |
| Financial debts170/4 | €605,000 | €516,000 | €427,000 | €338,000 | €249,000 | ▼ 26.3% |
| Amounts payable within one year42/48 | €678,761 | €680,344 | €694,735 | €696,755 | €726,360 | ▲ 4.2% |
| Current portion of amounts payable after more than one year42 | €89,000 | €101,521 | €94,098 | €89,000 | €89,000 | = |
| Financial debts43 | - | - | €68,246 | €4,735 | €5,052 | ▲ 6.7% |
| Credit institutions430/8 | - | - | €68,246 | €4,735 | €5,052 | ▲ 6.7% |
| Trade debts44 | €503,128 | €493,932 | €435,073 | €466,688 | €447,888 | ▼ 4.0% |
| Suppliers440/4 | €503,128 | €493,932 | €435,073 | €466,688 | €447,888 | ▼ 4.0% |
| Taxes, remuneration and social security45 | €31,592 | €23,783 | €39,023 | €51,350 | €38,771 | ▼ 24.5% |
| Taxes450/3 | €5,337 | €2,540 | €0 | €6,117 | €8,424 | ▲ 37.7% |
| Remuneration and social security454/9 | €26,254 | €21,243 | €39,023 | €45,233 | €30,347 | ▼ 32.9% |
| Other amounts payable47/48 | €55,041 | €61,108 | €58,295 | €84,982 | €145,649 | ▲ 71.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €70,183 | €36,257 | €9,431 | €11,539 | €43,820 | ▲ 280% |
| + Depreciation and write-downs630 | €112,067 | €53,968 | €54,834 | €53,847 | €52,833 | ▼ 1.9% |
| Operating cash flow (approximation) | €182,249 | €90,225 | €64,265 | €65,386 | €96,653 | ▲ 47.8% |
| Investment in fixed assets (approximation) | - | -€15,994 | -€3,590 | -€2,728 | -€451 | ▲ 83.4% |
| Change in cash | - | -€61,992 | -€83,159 | €10,184 | €38,976 | ▲ 283% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
21-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 21 days late
2024
23-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 84 days late
2023
29-10
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 90 days late
2022
02-09
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 33 days late
2021
31-12
Financial
Highest result since 2018net €70,183 ▲44%
Operating result €71,457, net result €70,183, both a record.
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 61 days late
2020
31-12
Financial
Back to profitnet €48,741
Net result €48,741 after 2 loss-making years.
17-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 17 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Chièvres · 2 establishment units since 2017
Ground area
2,048 m²
Building footprint
333 m²
Volume, LiDAR
2,604 m³
2 parcels, Wallonia · tallest building 12.0 m, ±3 floors. Linked by address, not a title deed.
7
companies at this address
See who is registered here
2 establishment units
Pharmadvance
since 20172.262.124.528
Pharmacie de la Grand-Place
since 20172.273.198.958
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51034B0490/00K000 | Wallonia | 1,252 m² | 1 · 265 m² | 9.4 m · 2 fl. |
| 57048D0564/00H000 | Wallonia | 796 m² | 1 · 67 m² | 12.0 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteLeuze-en-Hainaut2.273.198.958
Legal Entity Identifier
529900DW2NUMJ7GHH779
Similar companies · same sector, comparable size
APOTHEKE BOCKEN
BE 0801.615.522
Eupen · Eq €91,219
CURASAN
BE 0752.980.415
Zwalm · Eq €91,028
BALLIGAND
BE 0437.257.291
Jemeppe-sur-Sambre · Eq €91,369
De Baere OLV
BE 0793.872.546
Roosdaal · Eq €90,889
Apotheek Van Wambeke
BE 0886.144.488
Temse · Eq €90,863
Of 5,219 companies in this sector we hold annual accounts for 3,862. 3,354 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded24-02-2017
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0671818337
Also
9925:BE0671818337
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.